L-Arginine and L-Lysine stimulation on cultured human osteoblasts

P. Torricelli, M. Fini, G. Giavaresi, Roberto Giardino, S. Gnudi, A. Nicolini, A. Carpi

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Essential amino acids, such as L-Arginine (Arg) and L-Lysine (Lys), are involved in bone metabolism and growth. Our previous studies analyzed the effect of these amino acids on rat osteoblast cultures and in experimental animals. In this study, we evaluated the effect of L-Arg and L-Lys on cultured human osteoblasts. Primary human osteoblast cultures were divided into four groups: the Arg Group received 0.625 mg/ml per day of Arg, the Lys Group 0.587 mg/ml per day of Lys, the Arg-Lys Group received both amino acids, whereas the Control Group was sham-treated. After 7 days, the following parameters were tested in all groups: alkaline phosphatase (ALP), nitric oxide (NO), calcium (Ca), phosphorus (P), osteocalcin (OC), type I collagen (PICP), interleukin-6 (IL-6), transforming growth factor-beta 1 (TGF-β 1) on culture supernatant, platelet derived growth factor (PDGF), insulin-like growth factor-I (IGF-I), and MTT proliferation test on cells. Arg administration significantly increased ALP, NO, PICP and IGF-I production and reduced the level of IL-6. Lys administration over the same time interval mainly affected cell proliferation, as evidenced by the MTT test and immunostaining for PDGF. The same positive effects evidenced by the single administrations of the two amino acids resulted from their simultaneous administration. However, synergism could be demonstrated only for the decrease in the level of IL-6. Arg and Lys show a positive effect on human osteoblasts, which is related partly to the production of those factors required for matrix synthesis, and partly to the direct or mediated activation of cell proliferation.

Original languageEnglish
Pages (from-to)492-497
Number of pages6
JournalBiomedicine and Pharmacotherapy
Volume56
Issue number10
DOIs
Publication statusPublished - Dec 2002

Fingerprint

Osteoblasts
Lysine
Arginine
Interleukin-6
Platelet-Derived Growth Factor
Insulin-Like Growth Factor I
Amino Acids
Alkaline Phosphatase
Nitric Oxide
Cell Proliferation
Essential Amino Acids
Bone Development
Osteocalcin
Collagen Type I
Transforming Growth Factor beta
Phosphorus
Calcium
Control Groups

Keywords

  • Arginine
  • Human osteoblasts
  • Lysine
  • Osteoporosis

ASJC Scopus subject areas

  • Pharmacology

Cite this

L-Arginine and L-Lysine stimulation on cultured human osteoblasts. / Torricelli, P.; Fini, M.; Giavaresi, G.; Giardino, Roberto; Gnudi, S.; Nicolini, A.; Carpi, A.

In: Biomedicine and Pharmacotherapy, Vol. 56, No. 10, 12.2002, p. 492-497.

Research output: Contribution to journalArticle

Torricelli, P. ; Fini, M. ; Giavaresi, G. ; Giardino, Roberto ; Gnudi, S. ; Nicolini, A. ; Carpi, A. / L-Arginine and L-Lysine stimulation on cultured human osteoblasts. In: Biomedicine and Pharmacotherapy. 2002 ; Vol. 56, No. 10. pp. 492-497.
@article{26b8c37c8bd5475988dd9d6d2bbd7cb9,
title = "L-Arginine and L-Lysine stimulation on cultured human osteoblasts",
abstract = "Essential amino acids, such as L-Arginine (Arg) and L-Lysine (Lys), are involved in bone metabolism and growth. Our previous studies analyzed the effect of these amino acids on rat osteoblast cultures and in experimental animals. In this study, we evaluated the effect of L-Arg and L-Lys on cultured human osteoblasts. Primary human osteoblast cultures were divided into four groups: the Arg Group received 0.625 mg/ml per day of Arg, the Lys Group 0.587 mg/ml per day of Lys, the Arg-Lys Group received both amino acids, whereas the Control Group was sham-treated. After 7 days, the following parameters were tested in all groups: alkaline phosphatase (ALP), nitric oxide (NO), calcium (Ca), phosphorus (P), osteocalcin (OC), type I collagen (PICP), interleukin-6 (IL-6), transforming growth factor-beta 1 (TGF-β 1) on culture supernatant, platelet derived growth factor (PDGF), insulin-like growth factor-I (IGF-I), and MTT proliferation test on cells. Arg administration significantly increased ALP, NO, PICP and IGF-I production and reduced the level of IL-6. Lys administration over the same time interval mainly affected cell proliferation, as evidenced by the MTT test and immunostaining for PDGF. The same positive effects evidenced by the single administrations of the two amino acids resulted from their simultaneous administration. However, synergism could be demonstrated only for the decrease in the level of IL-6. Arg and Lys show a positive effect on human osteoblasts, which is related partly to the production of those factors required for matrix synthesis, and partly to the direct or mediated activation of cell proliferation.",
keywords = "Arginine, Human osteoblasts, Lysine, Osteoporosis",
author = "P. Torricelli and M. Fini and G. Giavaresi and Roberto Giardino and S. Gnudi and A. Nicolini and A. Carpi",
year = "2002",
month = "12",
doi = "10.1016/S0753-3322(02)00287-1",
language = "English",
volume = "56",
pages = "492--497",
journal = "Biomedicine and Pharmacotherapy",
issn = "0753-3322",
publisher = "Elsevier Masson SAS",
number = "10",

}

TY - JOUR

T1 - L-Arginine and L-Lysine stimulation on cultured human osteoblasts

AU - Torricelli, P.

AU - Fini, M.

AU - Giavaresi, G.

AU - Giardino, Roberto

AU - Gnudi, S.

AU - Nicolini, A.

AU - Carpi, A.

PY - 2002/12

Y1 - 2002/12

N2 - Essential amino acids, such as L-Arginine (Arg) and L-Lysine (Lys), are involved in bone metabolism and growth. Our previous studies analyzed the effect of these amino acids on rat osteoblast cultures and in experimental animals. In this study, we evaluated the effect of L-Arg and L-Lys on cultured human osteoblasts. Primary human osteoblast cultures were divided into four groups: the Arg Group received 0.625 mg/ml per day of Arg, the Lys Group 0.587 mg/ml per day of Lys, the Arg-Lys Group received both amino acids, whereas the Control Group was sham-treated. After 7 days, the following parameters were tested in all groups: alkaline phosphatase (ALP), nitric oxide (NO), calcium (Ca), phosphorus (P), osteocalcin (OC), type I collagen (PICP), interleukin-6 (IL-6), transforming growth factor-beta 1 (TGF-β 1) on culture supernatant, platelet derived growth factor (PDGF), insulin-like growth factor-I (IGF-I), and MTT proliferation test on cells. Arg administration significantly increased ALP, NO, PICP and IGF-I production and reduced the level of IL-6. Lys administration over the same time interval mainly affected cell proliferation, as evidenced by the MTT test and immunostaining for PDGF. The same positive effects evidenced by the single administrations of the two amino acids resulted from their simultaneous administration. However, synergism could be demonstrated only for the decrease in the level of IL-6. Arg and Lys show a positive effect on human osteoblasts, which is related partly to the production of those factors required for matrix synthesis, and partly to the direct or mediated activation of cell proliferation.

AB - Essential amino acids, such as L-Arginine (Arg) and L-Lysine (Lys), are involved in bone metabolism and growth. Our previous studies analyzed the effect of these amino acids on rat osteoblast cultures and in experimental animals. In this study, we evaluated the effect of L-Arg and L-Lys on cultured human osteoblasts. Primary human osteoblast cultures were divided into four groups: the Arg Group received 0.625 mg/ml per day of Arg, the Lys Group 0.587 mg/ml per day of Lys, the Arg-Lys Group received both amino acids, whereas the Control Group was sham-treated. After 7 days, the following parameters were tested in all groups: alkaline phosphatase (ALP), nitric oxide (NO), calcium (Ca), phosphorus (P), osteocalcin (OC), type I collagen (PICP), interleukin-6 (IL-6), transforming growth factor-beta 1 (TGF-β 1) on culture supernatant, platelet derived growth factor (PDGF), insulin-like growth factor-I (IGF-I), and MTT proliferation test on cells. Arg administration significantly increased ALP, NO, PICP and IGF-I production and reduced the level of IL-6. Lys administration over the same time interval mainly affected cell proliferation, as evidenced by the MTT test and immunostaining for PDGF. The same positive effects evidenced by the single administrations of the two amino acids resulted from their simultaneous administration. However, synergism could be demonstrated only for the decrease in the level of IL-6. Arg and Lys show a positive effect on human osteoblasts, which is related partly to the production of those factors required for matrix synthesis, and partly to the direct or mediated activation of cell proliferation.

KW - Arginine

KW - Human osteoblasts

KW - Lysine

KW - Osteoporosis

UR - http://www.scopus.com/inward/record.url?scp=0036902629&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036902629&partnerID=8YFLogxK

U2 - 10.1016/S0753-3322(02)00287-1

DO - 10.1016/S0753-3322(02)00287-1

M3 - Article

C2 - 12504270

AN - SCOPUS:0036902629

VL - 56

SP - 492

EP - 497

JO - Biomedicine and Pharmacotherapy

JF - Biomedicine and Pharmacotherapy

SN - 0753-3322

IS - 10

ER -